Paper
Cannabis and the skin.
Published May 14, 2021 · K. Shao, Campbell L. Stewart, J. Grant-Kels
Clinics in dermatology
Q2 SJR score
27
Citations
1
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Literature ReviewStudy Snapshot
Key takeawayCannabis shows potential in regulating pain, pruritus, and inflammation, making it a potential therapeutic agent for various dermatologic conditions.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
The potential role of cannabinoids in dermatology
Cannabinoids show potential in treating various skin conditions, offering an alternative to traditional treatments and offering anti-inflammatory, antipruritic, anti-ageing, and antimalignancy properties.
2020·80citations·T. Sheriff et al.·Journal of Dermatological Treatment
Journal of Dermatological Treatment
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
CBD has rare serious adverse effects, mainly elevated transaminases, convulsions, sedation, lethargy, and upper respiratory tract infections, which may be related to drug-drug interactions.
2020·50citations·R. G. dos Santos et al.·Expert Opinion on Drug Metabolism & Toxicology
Expert Opinion on Drug Metabolism & Toxicology
Cannabinoids in the Pathophysiology of Skin Inflammation
Cannabinoids show promise in treating skin inflammation and potentially antitumoral effects, but further controlled human studies are needed to confirm their definitive role and usefulness in clinical settings.
2020·68citations·C. Scheau et al.·Molecules
Molecules
Cannabinoids for the Treatment of Chronic Pruritus: A Review.
Cannabinoids show potential in reducing chronic pruritus symptoms in various dermatologic and systemic diseases, warranting controlled trials for confirmatory benefits.
2020·72citations·C. Avila et al.·Journal of the American Academy of Dermatology
Journal of the American Academy of Dermatology
SAT0303 DESIGN OF PHASE 3 STUDY OF LENABASUM FOR THE TREATMENT OF DERMATOMYOSITIS
Lenabasum shows potential in improving disease activity and function in dermatomyositis patients, but a larger, double-blind, randomized, placebo-controlled study is needed for confirmation.
2019·6citations·V. Werth et al.·Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases
Citations
Attenuation of 1-chloro-2,4-dinitrobenzene-induced inflammation in atopic dermatitis-like skin lesions in rats by a pyrrole containing FELL-NH 2 bioconjugate: Cannabinoid receptor type 1 involvement
Anandamide and a newly synthesized bioconjugate effectively reduce atopic dermatitis-like skin inflammation in rats, suggesting involvement of the cannabinoid system in skin defense.
2024·0citations·Konstantinos Papadakis et al.·Pharmacia
Pharmacia
Current and emerging drugs for the treatment of pruritus: an update of the literature
Current and emerging therapeutics for itch target various inflammation and neurosensory systems, offering potential relief beyond just reducing inflammation.
2024·2citations·R. H. Mahmoud et al.·Expert Opinion on Pharmacotherapy
Expert Opinion on Pharmacotherapy
Case report: Cannabinoid therapy for discoid lupus erythematosus in a dog
Cannabinoid therapy (CT) with CBD-rich full spectrum Cannabis oil significantly improved skin lesions and liver enzymes levels in a dog with discoid lupus erythematosus resistant to conventional treatments.
2024·1citation·Maria Eduarda Schmitz da Silva et al.·Frontiers in Veterinary Science
Frontiers in Veterinary Science
Cannabinoids and Their Receptors in Skin Diseases
Cannabinoids show promise for treating skin diseases like eczema, psoriasis, acne, and skin cancer, but more large-scale, randomized, controlled clinical trials are needed.
2023·11citations·E. Yoo et al.·International Journal of Molecular Sciences
International Journal of Molecular Sciences
Cannabis sativa L. in the cosmeceutical industry: prospects and biotechnological approaches for metabolite improvement
Cannabis sativa L. has potential applications in the cosmetic industry, and plant biotechnology can optimize production for sustainable supply of bioactive compounds, such as cannabinoids.
2023·1citation·Camila Moreno Lopes de Andrade et al.·South African Journal of Botany
South African Journal of Botany